1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer. (September 2015) - Tamiya, M.; Tamiya, A.; Kaneda, H.; Nakagawa, K.; Goto, K.; Yoh, K.; Okamoto, H.; Shimokawa, T.; Abe, T.; Tanaka, H.; Daga, H.; Takeda, K.; et al.